| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,845 |
Update - Notification of buy-back - APE
|
1 Jul 2025 8:32AM |
$17.450 |
$24.240 |
risen by
38.91%
|
|
| NH3 Clean Energy Limited (NH3) ORDINARY FULLY PAID |
Materials |
$78 |
NH3 McIntosh Graphite Project Partner GCM Releases PFS
|
1 Jul 2025 8:32AM |
$0.032 |
$0.110 |
risen by
243.75%
|
|
NH3 - Price-sensitive ASX Announcement
Full Release
Key Points
- NH3 Clean Energy Limited and partner GCM have published the Pre-Feasibility Study (PFS) for the McIntosh Graphite Project.
- The PFS demonstrates strong project economics, including favorable NPV and IRR figures.
- McIntosh Graphite Project will produce high-quality flake graphite for energy storage and clean energy markets.
- Significant graphite resources and potential for further resource growth are highlighted.
- The project is strategically positioned to support clean energy and battery manufacturing supply chains.
- Environmental sustainability and low-carbon operations are emphasized as key project features.
- Detailed production, capital, and operational expenditure estimates are provided in the study.
- Potential for value-add processing and vertical integration within NH3 Clean Energy's business strategy is discussed.
- The PFS results reinforce the attractiveness of the McIntosh Project as a long-term, sustainable graphite source.
- NH3 Clean Energy remains committed to project advancement and stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$41 |
Notification of cessation of securities - KRR
|
1 Jul 2025 8:31AM |
$0.008 |
$0.028 |
risen by
250%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$562 |
Presentation - Updated Pre-Feasibility Study
|
1 Jul 2025 8:31AM |
$0.520 |
$0.570 |
risen by
9.62%
|
|
SMI - Price-sensitive ASX Announcement
Full Release
Key Points
- SMI updated Pre-Feasibility Study for the Rise and Shine (RAS) Gold Project in New Zealand.
- Significant increase in JORC Resources to 78Mt @ 1.1 g/t Au for 2.8Moz, and Ore Reserves to 46Mt @ 1.2 g/t Au for 1.8Moz.
- Mine life extended to 12 years with annual production of approximately 120koz of gold in initial years.
- Low forecast All-In Sustaining Cost (AISC) of NZ$1,112/oz over life of mine.
- Post-tax NPV5% of NZ$1,301 million and IRR of 52% at NZ$3,150/oz gold price.
- Open-pit mining and conventional CIP gold processing plant proposed.
- Strong ESG focus with plans for progressive rehabilitation, community engagement, and low carbon footprint.
- Positive engagement with local iwi, landowners, and stakeholders regarding permitting and development.
- Scope for further resource expansion and production upside through exploration of additional targets.
- Significant economic and social benefits for the Central Otago region anticipated from project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Battery Minerals Limited (FBM) ORDINARY FULLY PAID |
Materials |
- |
Historical Shallow Drill Results at Burbanks East
|
1 Jul 2025 8:31AM |
$0.019 |
$0.065 |
risen by
242.11%
|
|
FBM - Price-sensitive ASX Announcement
Full Release
Key Points
- FBM reviewed historical shallow drilling data at Burbanks East.
- Significant lithium mineralisation identified in old drill holes.
- Some historical samples were not previously assayed for lithium.
- Re-assaying of pulps revealed new lithium pegmatite zones.
- Additional exploration including drilling and sampling is planned.
- The results highlight the lithium prospectivity of the Burbanks East Project.
- FBM aims to expand its lithium project portfolio in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$77 |
Paradigm Secures US$27M to Advance Phase 3 OA Trial
|
1 Jul 2025 8:31AM |
$0.305 |
$0.170 |
fallen by
44.26%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Paradigm Biopharmaceuticals secured US$27 million to fund its Phase 3 OA trial.
- The capital will be utilized to progress clinical development and approach potential commercialization of pentosan polysulfate sodium (PPS).
- Funding sources and detailed allocation of proceeds are described.
- The Phase 3 trial for OA pain management remains a central focus, with updates on recruitment and trial milestones.
- The announcement covers operational updates, partnership details, and market opportunity linked to OA treatment.
- Paradigm emphasizes the ongoing unmet need in OA and the potential impact of its investigational drug.
- Timelines for Phase 3 trial progression and upcoming regulatory milestones are presented.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$301 |
Update - Notification of buy-back - SVR
|
1 Jul 2025 8:31AM |
$1.675 |
$1.593 |
fallen by
4.93%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$562 |
Updated Pre-Feasibility Study - Bendigo Ophir Gold Project
|
1 Jul 2025 8:31AM |
$0.520 |
$0.570 |
risen by
9.62%
|
|
SMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Pre-Feasibility Study (PFS) for the Bendigo-Ophir Gold Project in Central Otago, New Zealand.
- Significant increase in Mineral Resources and Ore Reserves compared to previous estimates.
- PFS supports an underground mining operation with improved production targets.
- Unit costs, recovery rates, and project economics have all improved in the updated study.
- Technical studies include mining methods, ore processing, infrastructure, environmental management, and permitting.
- Financial analysis indicates robust returns, supported by higher gold prices and expanded resource base.
- The project remains open for further resource growth through additional drilling and exploration.
- Next steps include completing further resource definition, advanced feasibility studies, and commencing permitting processes.
- Study highlights strong project fundamentals and a clear path towards development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| iShares Core MSCI World Ex Australia ESG Leaders (AUD Hedged) ETF (IHWL) |
Financials |
$974 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$55.480 |
$63.640 |
risen by
14.71%
|
|
| Ishares Treasury ETF (IGB) |
Financials |
$296 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$100.380 |
$96.000 |
fallen by
4.36%
|
|
| iShares Core Corporate Bond ETF (ICOR) |
Financials |
$561 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$97.320 |
$93.500 |
fallen by
3.93%
|
|
| iShares Core MSCI Australia ESG Leaders ETF (IESG) |
Financials |
$441 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$32.500 |
$30.580 |
fallen by
5.91%
|
|
| iShares Core MSCI World Ex Australia ESG Leaders ETF (IWLD) |
Financials |
$1,554 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$63.110 |
$66.170 |
risen by
4.85%
|
|
| iShares Global Aggregate Bond ESG (AUD Hedged) ETF (AESG) |
Financials |
$340 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$97.720 |
$96.040 |
fallen by
1.72%
|
|
| iShares Yield Plus ETF (IYLD) |
Financials |
$100 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$100.710 |
$99.190 |
fallen by
1.51%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Update on status of discussions with CC Capital Partners
|
1 Jul 2025 8:30AM |
$3.630 |
$4.790 |
risen by
31.96%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$38 |
Funding boost for precision diagnostics Proteomics Facility
|
1 Jul 2025 8:30AM |
$0.325 |
$0.230 |
fallen by
29.23%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Proteomics International Laboratories Ltd received a $1.48 million funding boost from the Western Australian Government to support the establishment of a Precision Diagnostics Proteomics Facility.
- The funding will help establish a globally unique facility for the development and production of precision diagnostics, accelerating commercialisation of diagnostic tests including PromarkerD for diabetic kidney disease.
- The new facility will be housed in the Harry Perkins Institute of Medical Research at the QEII Medical Centre in Perth.
- The initiative aims to address the urgent need for precision diagnostics, especially for chronic diseases like diabetes and cancer, by enabling local production and reducing reliance on overseas suppliers.
- The facility will create new jobs and attract skilled talent in Western Australia while strengthening the region’s biotechnology and medical research sector.
- Proteomics International’s PromarkerD test is the world’s first predictive diagnostic test for diabetic kidney disease and is internationally recognised.
- The funding and facility are expected to support further diagnostic test development as well as industry partnerships and collaboration with universities and hospitals.
- The State Government sees this as a step towards transforming WA into a hub for advanced medical technology and commercialisation.
- The announcement highlights the alignment between government, academic, and industry interests in expanding the life sciences and health technology sectors.
- Proteomics International’s leadership expressed gratitude for the government’s support and emphasised the facility’s global significance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$257 |
Change of Director's Interest Notice
|
1 Jul 2025 8:30AM |
$0.365 |
$0.155 |
fallen by
57.53%
|
|
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$257 |
Notification regarding unquoted securities - PGC
|
1 Jul 2025 8:29AM |
$0.365 |
$0.155 |
fallen by
57.53%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$12,945 |
Appendix 3Y and 3Z - James McClements
|
1 Jul 2025 8:29AM |
$21.560 |
$65.500 |
risen by
203.80%
|
|
| Euro Manganese Inc (EMN) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$19 |
Notification of cessation of securities - EMN
|
1 Jul 2025 8:29AM |
$0.190 |
$0.133 |
fallen by
30.26%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$61,225 |
Appendix 3X - Yasmin Broughton
|
1 Jul 2025 8:29AM |
$15.280 |
$19.885 |
risen by
30.14%
|
|
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$53 |
Extension of Note and Loan Agreements
|
1 Jul 2025 8:29AM |
$0.044 |
$0.075 |
risen by
70.45%
|
|
SIX - Price-sensitive ASX Announcement
Full Release
Key Points
- Sprintex Limited extended the maturity dates of its Unsecured Convertible Note Deed and Unsecured Loan Agreement with SIX to 30 June 2024.
- The previous maturity date for both agreements was 30 June 2023.
- Interest on the convertible notes and the loan will continue at 10% per annum, payable quarterly in arrears.
- The extension provides Sprintex additional time and flexibility for financial management and strategic planning.
- Key terms such as conversion rights, repayment, and interest payments remain unchanged except for the new maturity date.
- Sprintex will keep shareholders updated on future developments regarding these agreements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$53 |
Notification of cessation of securities - SIX
|
1 Jul 2025 8:29AM |
$0.044 |
$0.075 |
risen by
70.45%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,769 |
Appendix 3C
|
1 Jul 2025 8:29AM |
$51.900 |
$42.570 |
fallen by
17.98%
|
|
Call 1300 880 160
Start a chat
Schedule a call
